Pages that link to "Q34529356"
Jump to navigation
Jump to search
The following pages link to Iron and Parkinson's disease (Q34529356):
Displaying 29 items.
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (Q24289511) (← links)
- Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein (Q24292317) (← links)
- Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases (Q28289119) (← links)
- Abnormal brain iron homeostasis in human and animal prion disorders (Q33417668) (← links)
- Alpha-synuclein is a cellular ferrireductase (Q33798034) (← links)
- Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates (Q34074933) (← links)
- Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? (Q34109492) (← links)
- Late-life hemoglobin and the incidence of Parkinson's disease (Q34427716) (← links)
- The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression (Q36012226) (← links)
- Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives (Q36090617) (← links)
- Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease (Q36382848) (← links)
- Molecular control of vertebrate iron homeostasis by iron regulatory proteins (Q36536936) (← links)
- Assessing of plasma levels of iron, zinc and copper in Iranian Parkinson's disease (Q36750001) (← links)
- NAD+ and NADH in neuronal death (Q37015565) (← links)
- Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease. (Q37181486) (← links)
- A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. (Q37258755) (← links)
- Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements (Q37402514) (← links)
- Metalloproteomics and metal toxicology of α-synuclein (Q37808957) (← links)
- Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases (Q37922607) (← links)
- Review: iron metabolism and the role of iron in neurodegenerative disorders (Q38155941) (← links)
- Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration (Q39653771) (← links)
- Alterations in the basal ganglia in patients with brain tumours may be due to excessive iron deposition (Q42469086) (← links)
- Transcriptional modulation in a leukocyte-depleted splenic cell population during prion disease (Q43614738) (← links)
- Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease (Q48213138) (← links)
- Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique. (Q48362227) (← links)
- High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease (Q48851886) (← links)
- Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. (Q51930607) (← links)
- Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in (Q82854230) (← links)
- Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration (Q92534736) (← links)